Physiologically responsive gene therapy

Alan W. Varley, Robert S. Munford

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The goal of physiologically responsive gene therapy is to allow a host's endogenous regulatory mechanisms to control the production of therapeutic proteins (effectors). Ideally, effector production would be switched on in response to specific signals, stay within therapeutic limits and be switched off when no longer needed. In this way, the unwanted consequences of constitutive, high-level effector expression could be avoided. While recent studies have shown that transgenes can be regulated within animal hosts, they have also highlighted significant problems that require much further research.

Original languageEnglish (US)
Pages (from-to)445-451
Number of pages7
JournalMolecular Medicine Today
Volume4
Issue number10
DOIs
StatePublished - Oct 1 1998

Fingerprint

Genetic Therapy
Transgenes
Therapeutics
Research
Proteins

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine

Cite this

Physiologically responsive gene therapy. / Varley, Alan W.; Munford, Robert S.

In: Molecular Medicine Today, Vol. 4, No. 10, 01.10.1998, p. 445-451.

Research output: Contribution to journalArticle

Varley, Alan W. ; Munford, Robert S. / Physiologically responsive gene therapy. In: Molecular Medicine Today. 1998 ; Vol. 4, No. 10. pp. 445-451.
@article{6f5dcb4edeb048849252083eb0e6db52,
title = "Physiologically responsive gene therapy",
abstract = "The goal of physiologically responsive gene therapy is to allow a host's endogenous regulatory mechanisms to control the production of therapeutic proteins (effectors). Ideally, effector production would be switched on in response to specific signals, stay within therapeutic limits and be switched off when no longer needed. In this way, the unwanted consequences of constitutive, high-level effector expression could be avoided. While recent studies have shown that transgenes can be regulated within animal hosts, they have also highlighted significant problems that require much further research.",
author = "Varley, {Alan W.} and Munford, {Robert S.}",
year = "1998",
month = "10",
day = "1",
doi = "10.1016/S1357-4310(98)01333-1",
language = "English (US)",
volume = "4",
pages = "445--451",
journal = "Trends in Molecular Medicine",
issn = "1471-4914",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Physiologically responsive gene therapy

AU - Varley, Alan W.

AU - Munford, Robert S.

PY - 1998/10/1

Y1 - 1998/10/1

N2 - The goal of physiologically responsive gene therapy is to allow a host's endogenous regulatory mechanisms to control the production of therapeutic proteins (effectors). Ideally, effector production would be switched on in response to specific signals, stay within therapeutic limits and be switched off when no longer needed. In this way, the unwanted consequences of constitutive, high-level effector expression could be avoided. While recent studies have shown that transgenes can be regulated within animal hosts, they have also highlighted significant problems that require much further research.

AB - The goal of physiologically responsive gene therapy is to allow a host's endogenous regulatory mechanisms to control the production of therapeutic proteins (effectors). Ideally, effector production would be switched on in response to specific signals, stay within therapeutic limits and be switched off when no longer needed. In this way, the unwanted consequences of constitutive, high-level effector expression could be avoided. While recent studies have shown that transgenes can be regulated within animal hosts, they have also highlighted significant problems that require much further research.

UR - http://www.scopus.com/inward/record.url?scp=0031661337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031661337&partnerID=8YFLogxK

U2 - 10.1016/S1357-4310(98)01333-1

DO - 10.1016/S1357-4310(98)01333-1

M3 - Article

C2 - 9793933

AN - SCOPUS:0031661337

VL - 4

SP - 445

EP - 451

JO - Trends in Molecular Medicine

JF - Trends in Molecular Medicine

SN - 1471-4914

IS - 10

ER -